Cytopoint

Cytopoint™ Injection: Targeted, Long-Lasting Relief for Atopic Dermatitis

Cytopoint™ is an innovative, biological therapy designed to aid in the reduction of clinical signs associated with atopic dermatitis in dogs. Unlike oral medications, Cytopoint is administered as a ready-to-use, sterile liquid by subcutaneous injection (under the skin) by your veterinarian or trained staff.

Targeted Immunomodulation

• Mechanism: Cytopoint™ contains a caninized monoclonal antibody (mAb) against interleukin-31 (IL-31). IL-31 is a key protein that sends itch signals from nerve cells to the brain. By neutralizing IL-31, Cytopoint breaks the itch cycle.

• Benefits: Provides sustained relief from itching and inflammation associated with atopic dermatitis.

Product Details

• Active Ingredient: Monoclonal Antibody (mAb) against IL-31

• Approved Species: Dog

• Uses: Immunomodulator

• Form: Suspension for Subcutaneous administration.

Prescription and Administration Required

Cytopoint™ is a prescription-only medication that requires professional administration via injection. A valid veterinary prescription is required for purchase.